Delaware Judge’s Surprising Ruling Shakes Up Aurion Biotech’s IPO Plans
A Delaware judge issued a mixed verdict in Aurion Biotech’s IPO case, blending victory and setback. The legal challenges faced by Aurion reflect the competitive and complex nature of the biotech industry. The ruling introduces uncertainty for stakeholders regarding the company’s growth
